A Multi-Center, Observational Registry of Subjects With Secondary Hyperparathyroidism (HPT) and Chronic Kidney Disease (CKD)
NCT00189501 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 1000
Last updated 2007-12-28
Summary
Objectives include description of current practices; assessment over time of K/DOQI goals, clinical outcomes, health resource utilization(HRU) and patient reported outcomes (PRO) and the impact of Sensipar® on these parameters
Conditions
- Nephrology
Interventions
- DRUG
-
Sensipar®
Sponsors & Collaborators
- lead INDUSTRY
Principal Investigators
-
MD · Amgen
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2004-12-31
More Related Trials
-
IMpact of hyPeRkalaemia on thErapy With Renin angiotenSin aldoSterone System Inhibitors
NCT04510792 ·Status: WITHDRAWN
-
Carvedilol and Micro T-Wave Alternans in Hypertensives With Chronic Kidney Disease
NCT00638222 ·Status: TERMINATED ·Phase: NA
-
E.V.O.L.V.E. Trial™: EValuation Of Cinacalcet Hydrochloride (HCl) Therapy to Lower CardioVascular Events
NCT00345839 ·Status: COMPLETED ·Phase: PHASE3
-
A Study of Atrasentan on Reducing Albuminuria in Type 2 Diabetic Nephropathy Treated With Renin-Angiotensin System Inhibitors
NCT00920764 ·Status: COMPLETED ·Phase: PHASE2
-
Efficacy and Safety of KBP-5074 in Uncontrolled Hypertension and Moderate or Severe Chronic Kidney Disease (CKD)
NCT04968184 ·Status: TERMINATED ·Phase: PHASE3
-
Subacute Effect of Tolvaptan on Total Kidney Volume in Adult Patients With Autosomal Dominant Polycystic Kidney Disease
NCT03596957 ·Status: UNKNOWN ·Phase: PHASE4
-
Optimal HCTZ Cessation for Diagnosis of Hyperparathyroidism
NCT02591160 ·Status: COMPLETED ·Phase: NA
-
Efficacy and Safety of Lorundrostat in Addition to Sodium-Glucose Cotransporter-2 Inhibitors (SGLT2i) in Subjects With Hypertension and Chronic Kidney Disease (CKD) With Albuminuria
NCT06150924 ·Status: COMPLETED ·Phase: PHASE2
-
Safety, Tolerability and Pharmacokinetics of KBP-5074 in Healthy Subjects and Subjects With Renal Impairment
NCT02653014 ·Status: COMPLETED ·Phase: PHASE1
-
A Study in Subjects With Renal Impairment Compared to Subjects With Normal Renal Function
NCT05895812 ·Status: COMPLETED ·Phase: PHASE1
-
Domperidone and the Risk of Serious Adverse Events
NCT07098078 ·Status: COMPLETED
-
The Use of Ambulatory Blood Pressure Monitors to Assess Angiotensin Converting Enzyme Inhibitors
NCT02623036 ·Status: UNKNOWN ·Phase: PHASE1
-
Hypertension in Hemodialysis Patients (Aim 3)
NCT00582114 ·Status: TERMINATED ·Phase: PHASE3
-
Electronic Alert to Improve Testing For Primary Aldosteronism in Patients With Hypertension
NCT05925569 ·Status: ACTIVE_NOT_RECRUITING ·Phase: NA
-
Comparison of Single and Combination Diuretics in Low-Renin Hypertension
NCT02351973 ·Status: UNKNOWN ·Phase: PHASE4
-
Influence of Polymorphisms in the ATP6V1 Gene of the V-ATPase on the Development of Incomplete Distal Renal Tubular Acidosis
NCT01690039 ·Status: COMPLETED
-
Outcome of ADPKD With Octreotide LAR
NCT06193616 ·Status: ACTIVE_NOT_RECRUITING
-
The Effect of Amiloride and Spironolactone in Healthy Persons
NCT00857909 ·Status: COMPLETED ·Phase: PHASE1
-
Study to Evaluate the Pharmacokinetics of CIN-107 in Subjects With Varying Degrees of Renal Function
NCT05470725 ·Status: COMPLETED ·Phase: PHASE1
-
High Dose Ace Inhibitor Therapy Versus Combination of ACE and ARB Therapy
NCT00212901 ·Status: COMPLETED ·Phase: NA
-
Efficacy and Safety Study of Second-Line Treatment for Hypertension With Autosomal Dominant Polycystic Kidney Disease(ADPKD)
NCT00890279 ·Status: UNKNOWN ·Phase: PHASE2
-
A Study in Male and Female Participants (After Menopause) With Mild to Moderate High Blood Pressure to Learn How Safe the Study Treatment BAY3283142 is, How it Affects the Body and How it Moves Into, Through and Out of the Body After Taking Single and Multiple Doses
NCT05491642 ·Status: COMPLETED ·Phase: PHASE1
-
Assessment of Hyperkalemia's Illness and Treatment Burden in Chronic Kidney Disease and Heart Failure Patients: HK Registry Pilot Study
NCT04466969 ·Status: COMPLETED
-
Renal Artery Stenting in Patients With Documented Resistant Hypertension and Atherosclerotic Renal Artery Stenosis (ANDORRA)
NCT02539810 ·Status: TERMINATED ·Phase: PHASE4
-
Single and Twice-daily Dosing of Ramipril on Renal Function in Chronic Kidney Disease Patients With Reduced Ejection Fraction Heart Failure
NCT07259512 ·Status: RECRUITING ·Phase: PHASE4